PHARMA MIX M 300

ACTIVE HALF-LIFE 5-6 days
CLASSIFICATION Anabolic Steroid
DOSAGE Men: 300-900 mg/week
ACNE Yes
WATER RETENTION Low
HBR No
HEPATOTOXICITY Low
AROMATIZATION No
CARRIER OIL Grapeseed Oil
MANUFACTURER Pharmacom Labs - US
LAB TEST See Document
WAREHOUSE USA Warehouse 4
SUBSTANCE Drostanolone Enanthate, Drostanolone Propionate

Introducing PHARMAMIX M 300, a powerful blend of two drostanolone esters: propionate and enanthate. This expertly crafted formulation ensures a swift yet sustained release of drostanolone, making it perfect for extended cycles focused on achieving high-quality lean muscle mass and a sculpted physique. Say goodbye to unwanted subcutaneous water retention typically seen with long esters! PHARMAMIX M 300 synergizes seamlessly with testosterone and trenbolone mixes (PHARMA SUST 300, 500, PHARMA 3-TREN) as well as long-acting testosterone and trenbolone esters (PHARMA TEST E300, E500, C250; PHARMA TREN E200, H100). For those seeking a similar blend, check out our successful product, PHARMA MIX 6, which has garnered impressive sales, much like PHARMA MIX 2.

Originally developed by Syntex in 1959 and launched in 1970 under the brand name Masteron, drostanolone is an injectable anabolic steroid derived from dihydrotestosterone (DHT). Renowned for its robust anabolic properties and anti-estrogenic effects, drostanolone was FDA-approved for treating inoperable breast cancer in postmenopausal women, a recognition that has spread across various global markets.

Masteron mimics the biological effects of DHT, making its impact especially notable during cutting cycles. To fully experience its advantages, users should ideally be in a lean state. This non-aromatizing compound ensures no water retention and offers a mild diuretic effect similar to stanozolol, enhancing muscle density, definition, and overall aesthetics. With its lipolytic properties, drostanolone can help decrease body fat by approximately 5-7%, making it a top choice for track and field athletes and bodybuilders aiming to maintain their weight class.

While drostanolone's bulking effects are relatively modest?similar to those of Primobolan at higher doses?many other anabolic steroids may be more effective for mass gains. Notably, Masteron does not convert to estrogen and boasts anti-estrogenic qualities by binding to aromatase, which contributes to its use in breast cancer therapy.

In summary, drostanolone offers benefits akin to stanozolol but without the common side effects associated with Winstrol. It does not increase tendon brittleness, deplete joint fluid, and presents fewer adverse effects on blood cholesterol compared to stanozolol. Thus, for those engaging in cutting cycles, drostanolone emerges as a safer and more sensible alternative to stanozolol.